William P'Pool (NASDAQ:POOL), Senior Vice President, General Counsel, and Corporate Secretary of Prestige Consumer Healthcare Inc. (NYSE:PBH), sold 8,987 shares of the company's common stock on November 12, 2024. The shares were sold at a weighted average price of $81.85, totaling $735,585. Following this transaction, P'Pool retains ownership of 20,058 shares in the company. The stock sale was executed in multiple transactions within a price range of $81.58 to $81.85, according to a filing with the Securities and Exchange Commission.
In other recent news, Prestige Consumer Healthcare Inc. disclosed mixed results for the second quarter of 2025. Despite a slight dip in sales to $284 million, the company noted an increase in earnings per share (EPS) to $1.09 and generated a free cash flow of $68 million. Challenges with the Clear Eyes brand due to supply chain issues were reported, yet international growth, particularly with the Hydralyte brand and Canadian portfolio, helped counterbalance the decline. Prestige Consumer Healthcare also reduced its debt by $40 million, achieving a leverage ratio of 2.7x.
The company anticipates fiscal year revenues to fall between $1.125 billion and $1.140 billion, with an adjusted EPS forecast of $4.40 to $4.46. It also projects Q3 revenue to be approximately $286 million. In terms of future expectations, Prestige Consumer Healthcare aims for organic growth around 1% for the current year, with long-term growth projected at 2%-3%.
These recent developments underline the company's commitment to capital deployment strategies, including share repurchases and potential mergers and acquisitions. Despite present challenges, Prestige Consumer Healthcare's management remains confident in the strength of their brands and the company's capacity to capitalize on growth opportunities.
InvestingPro Insights
The recent stock sale by William P'Pool comes at a time when Prestige Consumer Healthcare Inc. (NYSE:PBH) is experiencing strong market performance. According to InvestingPro data, the company's stock is trading near its 52-week high, with a robust return of 16.2% over the last month and 20.53% over the past three months. This upward trend aligns with the company's solid financial position, as evidenced by its market capitalization of $4.09 billion and a price-to-earnings ratio of 19.9.
InvestingPro Tips highlight that PBH has been profitable over the last twelve months and analysts predict continued profitability this year. The company's strong financial health is further underscored by its liquid assets exceeding short-term obligations, suggesting a stable financial foundation.
However, investors should note that 5 analysts have revised their earnings downwards for the upcoming period, which may indicate some caution in future expectations. Additionally, the RSI suggests the stock is in overbought territory, which could signal a potential for price consolidation in the near term.
For those seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for Prestige Consumer Healthcare Inc., providing deeper insights into the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.